Taysha Gene Therapies (TSHA) Interest Expenses (2020 - 2026)
Taysha Gene Therapies' Interest Expenses was $6,000 in Q2 2026, down 64.7% from $17,000 a year earlier and down 33.3% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Interest Expenses (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Taysha Gene Therapies' Interest Expenses was $42,000 through Jun 30, 2026, down 48.8% year-over-year; for FY2025, it was $63,000, down 38.2% from FY2024.
- Interest Expenses shows a five-year compound annual growth rate of 17.6% (FY2020 to FY2025).
- In earlier years, Interest Expenses was $102,000 in FY2024 (-98.0%), $5 million in FY2023 (+31.6%), $3.8 million in FY2022 (+166.0%) and $1.43 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Interest Expenses since Q3 2020.
- Compared with a year earlier, Interest Expenses has declined for 11 straight quarters, with an average decline of 58.4% over the last eight quarters.
- The best year-over-year quarter for Interest Expenses over five years was Q2 2022 (growth of 283.0%); the worst was Q3 2024 (a decline of 98.4%).
- Per Business Quant data, TSHA's Interest Expenses in the three quarters before Q2 2026 was $9,000 (Q1 2026), $12,000 (Q4 2025) and $15,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Taysha Gene Therapies | 1.30 Bn | -44.66 Mn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 713,000.00 |
| Sep 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 743,000.00 |
| Mar 31, 2022 | 672,000.00 |
| Dec 31, 2021 | 691,000.00 |
| Sep 30, 2021 | 543,000.00 |
API Access
Taysha Gene Therapies Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();